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Disease progression in human immunodeficiency virus type-1 (HIV-1)-infected individuals is frequently accompanied by declining CD4
cell numbers and the acquisition of a T-tropic (X4) or dual tropic (R5X4) phenotype. Understanding the mechanism of CD4 cell loss in HIV-1
infection is essential for the development of effective therapeutic strategies. In this study, donor populations of peripheral blood mononuclear
cells (PBMCs) were selected for their ability to support an equivalent acute infection by both R5 and X4 virus phenotypes. This demonstrated
that CD4+ T-lymphocyte loss was due to the gp120 region of Env and was replication independent. Furthermore, apoptosis was only detected
in cells infected with an X4 virus after the majority of CD4+ T-lymphocyte loss had occurred. These observations indicate that the CD4+ T-
lymphocyte loss in an X4 HIV-1 infection is not directly mediated by apoptosis, although apoptosis may be induced in the remaining cell
population as a consequence of this CD4+ T-lymphocyte loss.
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Introduction shown that peripheral blood mononuclear cells (PBMCs)Disease progression in human immunodeficiency virus
type 1 (HIV-1)-infected individuals is accompanied by a
decline in CD4+ lymphocyte numbers. These cells play a
major role in the regulation and function of the immune
response, and their loss predisposes the host to life-threat-
ening opportunistic infections. A possible mediator of this
cell loss is virus-induced apoptosis. Previous studies have0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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ous and activation-induced apoptosis more frequently than
PBMCs from uninfected individuals (Gougeon, 1996;
Groux et al., 1992; Karmochkine et al., 1998; Meyaard et
al., 1992; Oyaizu et al., 1993, 1995; Pandolfi et al., 1995).
However, the mechanism underlying HIV-1-induced apo-
ptosis, and indeed whether apoptosis is truly the key propo-
nent of CD4+ lymphocyte loss, remains poorly understood.
Apoptosis is a genetically controlled process that medi-
ates the self-destruction of redundant, aberrant, or injured
cells. Most animal viruses have developed mechanisms to
delay apoptosis to allow the replication of viral progeny
(Benedict et al., 2002). However, animal viruses also induce
apoptosis later in the infection cycle to facilitate the spread
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response. Several HIV-1 proteins, including Tat, Vpr, Vpu,
Nef, and Env, have been implicated in both pro- and anti-
apoptotic processes (Akari et al., 2001; Casella et al., 1999;
Roshal et al., 2001).
The accessory protein Nef, although not essential for
viral replication, exerts a significant effect on replication
efficiency and pathogenesis (Deacon et al., 1995; Kestler
et al., 1991; Kirchhoff et al., 1995; Salvi et al., 1998). Nef
can downmodulate cell surface expression of CD4 (Garcia
and Miller, 1991) and MHC class I (Schwartz et al., 1996)
in HIV-1-infected cells and has more recently been shown
to modulate T-cell signaling (Renkema and Saksela, 2000)
through a TCR-associated signaling complex (Simmons et
al., 2001). Stimulation of the T-cell receptor by Nef
appears to prime the infected cell for HIV-1 replication.
But, perhaps more significant is the ability of Nef to
facilitate macrophage-mediated resistance to apoptosis by
inducing an anti-apoptotic response in the early phase of
virus replication (Mahlknecht et al., 2000) and promoting a
pro-apoptotic response in the late phase of virus replication
(Greenway et al., 2003).
The phenotype of the HIV-1 Env glycoprotein is an
important determinant of virus tropism and pathogenesis.
Env mediates the binding and entry of virus into cells
expressing the CD4 receptor. However, virus infection also
requires the interaction of Env with a secondary co-receptor.
Viral infection of primary macrophages (M-tropic) requires
the expression and use of the CCR5 co-receptor (R5),
whereas virus infection of CD4+ T-lymphocytes and T-cell
lines (T-tropic) requires expression and use of the CXCR4
co-receptor (X4). Viruses with an R5 phenotype are found
early in infection, whereas X4 or dual-tropic viruses (R5X4)
are more cytopathic and predominate late in the infection
process. These differences suggest that changes in Env that
accompany disease progression may be directly related to
the pathogenicity of the virus.
In vitro, cross-linking of CD4 with a recombinant form
of the gp120 Env subunit (Laurent-Crawford et al., 1993) or
exogenous expression of HIV-1 Env (Laurent-Crawford et
al., 1995) has been shown to promote apoptosis in T-cell
lines. In HIV-1-infected individuals, the ability of PBMC to
undergo apoptosis has been correlated with increased viral
load and disease progression (Gougeon et al., 1996; Pan-
dolfi et al., 1995). Therefore, HIV-1-mediated apoptosis
may be induced by the increase in viral load that accom-
panies disease progression or by a change in viral phenotype
from R5 to X4 or R5X4.
A difficulty associated with the study of HIV-1 Env
phenotype in vitro is the innate differences in the replication
ability and kinetics of these virus types in cell lines and
primary cell cultures. This had led to the conclusion that
differences in CD4+ lymphocyte depletion from PBMC
infected with primary M- and T-tropic virus strains may
be related to viral replication (Zhang et al., 1997). However,
similar replication kinetics, achieved by infection of PBMCwith different multiplicities of infection, of isogenic X4 and
R5 virus phenotypes indicated that CD4+ lymphocyte loss
was greater in X4-infected cultures (Penn et al., 1999). Thus
suggesting that CD4+ lymphocyte loss was independent of
virus replication kinetics. The mechanism of HIV-1-medi-
ated cell loss also remains controversial following the
observation that death of CD4+ lymphocytes was primarily
induced by necrosis (Lenardo et al., 2002) despite previous
studies reporting the detection of apoptosis in X4-infected
PBMC (Gandhi et al., 1998; Herbein et al., 1998b) or a
combination of both apoptosis and necrosis (Plymale et al.,
1999).
In the current study, the effect of viral phenotype, with
respect to Env, on CD4+ lymphocyte loss and induction of
apoptosis was investigated in a model of acute virus
replication in primary activated, synchronized PBMC. In a
detailed kinetic analysis, it was found that cell loss occurred
in PBMC infected with HIV-1 with an X4 but not R5 Env
phenotype and that apoptosis was only detected in X4-
infected cells after the loss of CD4+ T-lymphocytes. Our
data suggest that apoptosis associated with HIV-1 infection
is a consequence of CD4+ T-lymphocyte loss and not the
primary mediator.Results
CD4 downmodulation is followed by cell death in PBMC
infected with T-tropic/X4 isolates of HIV-1
Primary HIV-1 and reference isolates were used to
investigate the relationship between viral tropism and viru-
lence in PBMC. MBC200 was isolated from PBMC and
replicates in primary T-lymphocytes and T-cell lines and
uses CXCR4 for viral entry (Kiernan et al., 1990; Oelrichs
et al., 2000). MBC925 and MBC676 were isolated from
CSF and brain, respectively, and replicate in macrophages
and PBMC (Cameron et al., 1996; Oelrichs et al., 2000).
Both viruses have been shown to use CCR5 for viral entry
(Oelrichs et al., 2000). These isolates were used to infect
mixed populations of PHA-stimulated PBMC (PHA-
PBMC). Cell-free reverse transcriptase (RT) activity indi-
cated that all viruses replicated to high levels in PBMC and
peaked between days 7 and 11 postinfection (Fig. 1a). Flow
cytometry analysis for CD4+/CD3+ PBMC indicated that
CD4 expression had decreased by day 7 postinfection in all
HIV-1-infected cultures relative to the mock-infected con-
trol, albeit more dramatically in cultures infected with LAI
and MBC200 (Fig. 1b). By 14 days postinfection, there
were no CD4+ cells detected in cultures infected with LAI
and MBC200, whereas the percent of CD4+ cells in cultures
infected with AD8 and MBC925 was reduced by approxi-
mately 50% relative to mock-infected cultures and by 75%
in MBC676-infected cultures.
To determine whether the loss of CD4 expression was
due to CD4 receptor downregulation (Chen et al., 1996) or
Fig. 1. Characterization of CD4 antigen expression on PBMC infected with
primary HIV-1 isolates. Mixed populations of PHA-PBMC were infected
with primary HIV-1 isolates MBC200, MBC925, and MBC676 or
molecular clones LAI and AD8 at a moi of 0.0001 or mock infected.
Virus replication kinetics were determined by cell-free RT activity (a). The
percentage of CD4+ lymphocytes was determined by flow cytometry
analysis of cells labeled with anti-CD4-FITC/anti-CD3-PE antibodies (b).
Results of a representative infection are shown.
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CD4 /CD3+ lymphocyte population that could not be
attributed to the outgrowth of a CD8+ lymphocyte popula-
tion. This was achieved by comparing the percentage of
CD4 /CD3+ cells with the percentage of CD4 /CD8+
cells obtained through parallel dual fluorescence labeling of
infected cell cultures (Fig. 2). In LAI- and MBC200-
infected cultures, CD4 downmodulation was followed by
cell death 14 days postinfection. In contrast, the loss of
CD4+ cells from cultures infected with M-tropic/R5 HIV-1
was mostly due to the downmodulation of CD4 expression.
This population is represented as CD4 /CD3+ cells that
are not CD8+ (summarized Table 1). Our results demon-
strate that both T-tropic/X4 and M-tropic/R5 HIV-1 pheno-
types downmodulate CD4 expression following initial viral
entry. However, only in PBMC populations infected with
the T-tropic/X4 phenotype was this CD4 downmodulation
followed by significant cell death.
Interestingly, unlike the other M-tropic isolates studied
here, the decrease in CD4 expression observed in cultures
infected with MBC676 was also partly due to cell loss
despite the M-tropic/R5 phenotype of this viral isolate
(Table 1). This may be attributable to strong virulence
described for M-tropic HIV-1 isolated from the brain (Gorry
et al., 2002a).The Nef accessory protein does not mediate CD4+
lymphocyte loss in primary PBMC cultures
The HIV-1 accessory protein Nef has been implicated in
CD4+ lymphocyte survival (Deacon et al., 1995; Kestler et
al., 1991; Kirchhoff et al., 1995; Mahlknecht et al., 2000;
Salvi et al., 1998). HIV-1 isolates from the Sydney blood
bank cohort (SBBC) encode a natural deletion within the nef
gene (Deacon et al., 1995) and consequently do not express
a Nef protein. The CD4+ lymphocyte survival of two SBBC
isolates, MBCC18 (R5) and MBCD36 (dual tropic R5/X4),
was used to investigate the importance of Nef in CD4+
lymphocyte survival. In addition, NL4.3 was included as a
prototypic X4 virus, and a chimeric clone NLAD composed
of the gp120 region of AD8 (R5) in an NL4.3 background
was included as a prototypic R5 virus. The co-receptor use
of these viruses was confirmed in Cf2-Luc cells (Table 2).
Viruses derived from nef-deleted clones of NL4.3
(NL4.3Dnef) and NLAD (NLADDnef) were included to
directly assess the effect of Nef relative to Env phenotype on
CD4+ lymphocyte survival.
The kinetics of replication of MBCD36 were similar to
that of the molecular clones of NL4.3, NL4.3Dnef, NLAD,
and NLADDnef. Whereas the replication kinetics of the
primary isolate MBCC18 were delayed by 2 days in the
same donor cell population (Fig. 3a). Analysis of the percent
of CD4+ lymphocytes in the total population indicated that
minimal cell killing occurred in PBMC infected with a virus
with an R5 phenotype (Fig. 3b; MBCC18, NLAD, or
NLADDnef). However, CD4+ lymphocyte loss was
detected in PBMC infected with a virus with an X4 or dual
tropic phenotype (Fig. 3b; NL4.3, NL4.3Dnef, or
MBCD36). Furthermore, the degree of cell loss was not
dramatically altered for nef-deleted viruses with an R5, X4,
or R5X4 phenotype. Therefore, in this model of HIV-1
infection, the Nef protein did not significantly alter virus-
mediated cell death.
CD4+ lymphocyte loss in primary PBMC cultures is
determined by gp120 Env and is independent of viral
replication kinetics
Having established that the X4 phenotype of HIV-1
causes CD4+ cell death in PBMC, irrespective of the
presence of the Nef accessory protein, we next used well-
characterized molecular clones NL4.3, NLAD, and AD8 to
specifically define the role of virus replication and the
gp120 region of Env in cell killing.
Mixed populations of PHA-PBMC were infected with an
equivalent multiplicity of infection (moi) of each virus and
replication kinetics, and CD4 expression was monitored
over the course of the infection (Figs. 4a and c). Loss of
CD4 expression in PBMC infected with NL4.3 occurred
coincident with virus replication between days 5 and 10
postinfection. At the time of peak virus replication, day 11
postinfection, the majority of CD4 expression had been lost.
Fig. 2. Evidence of CD4 receptor downmodulation in PBMC infected with primary HIV-1 isolates. Flow cytometry analysis of a mixed population of PHA-
PBMC 14 days after infection with LAI or AD8. Dual fluorescence labeling with anti-CD4-FITC/anti-CD8-PE and anti-CD4-FITC/anti-CD3-PE antibodies
identified a population of CD3+ cells (circled) in the AD8-infected PBMCs that were not CD4+ or CD8+. This CD8 and CD3+/CD4 population
represents PBMC in which the CD4 receptor has been downregulated. This population of cells was not detected in day 14 LAI infected PBMC, although
receptor downregulation was observed earlier in PBMC infected with X4 virus (Table 1).
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relative to NL4.3 and was associated with a less dramatic
loss of CD4 expression.
It has been suggested that the acute nature of the
replication kinetics of the X4 viral phenotype may be
responsible for the rapid cell killing by this virus phenotype
relative to an R5 phenotype (Zhang et al., 1997). To
determine whether CD4 cell loss in NL4.3 virus-infected
cultures was a function of replication kinetics or an intrinsic
function of Env, donor PBMC populations were screened to
identify preferred donor populations in which all three HIV-
1 virus phenotypes replicated with equivalent efficiency.
Synchronization of the cell-population was further used to
enhance virus replication. In contrast to previous studies
(Penn et al., 1999), this approach increased the infectivity of
the R5 viral phenotype and resulted in near equivalent
replication of the three virus phenotypes over the acute
phase of infection, days 2–6 postinfection (Fig. 4b). Char-
acterization of the cell populations that supported equivalent
replication of both the R5 and X4 viral phenotype indicated
that the preferred populations expressed high levels of CD4
and CXCR4 and low levels of CCR5 (data not shown). This
is typical for resting and PHA-stimulated PBMC after
culture for several days in IL-2 (Bleul et al., 1997; Chanel
et al., 2002; Platt et al., 1998). Although CCR5 expression
on PBMC has been shown to correlate with susceptibility to
infection (Wu et al., 1997), relatively low levels of CCR5
(10%) and high levels of CXCR4 (70%) on anti-CD3/IL-2-stimulated PBMC have been shown to support similar levels
of R5 and X4 virus infection (Wu et al., 1997).
In all HIV-1-infected cultures, there was a loss of CD4
expression 2–3 days postinfection, which coincided with
virus production (Fig. 4d). However, CD4 expression con-
tinued to decline rapidly in NL4.3-infected cells over the
exponential phase of virus production, whereas the rate of
CD4 loss in NLAD- and AD8-infected cultures was less
dramatic. Interestingly, the rapid replication kinetics
exhibited by NLAD and AD8 in the preferred synchronized
PHA-PBMC population was also associated with an in-
creased loss of CD4 expression when compared to that of
the mixed PBMC culture (compare Figs. 4c and d). None-
theless, the cytopathicity of the X4 virus was greater than
that of the R5 virus phenotype despite equivalent replication
kinetics, thus confirming that CD4 cell loss in HIV-1-
infected cultures is not a function of virus replication (Penn
et al., 1999), and indicating that Env, in particular the gp120
region, is a sole mediator of X4-virus-mediated cell loss.
Apoptosis is not detected in whole cell population of
primary PBMC infected with HIV-1
Both apoptosis and necrosis have been implicated as
mechanisms of HIV-1-induced cell death. As this may
reflect a temporal difference in virus replication, PBMC
cultures were sampled daily over the lag and exponential
phases of replication and at the peak of virus production to
Table 1
The CD4 receptor is downmodulated in HIV-1-infected PBMC
Isolate (Day PI) CD4 /CD8+ CD4 /CD3+
LAI (4) 31.49 70.70
LAI (7) 63.78 78.46
LAI (14)a 94.11 96.21
MBC200 (4) 40.32 55.13
MBC200 (7) 66.73 78.48
MBC200 (14) 86.80 94.86
AD8 (4) 32.05 44.51
AD8 (7) 30.09 46.46
AD8 (14)a 35.24 62.37
MBC676 (4) 32.04 41.41
MBC676 (7) 36.66 52.15
MBC676 (14) 49.26 75.78
MBC925 (4) 29.80 44.08
MBC925 (7) 30.08 54.67
MBC925 (14) 37.38 62.31
Mock (4) 34.20 43.09
Mock (7) 30.56 31.73
Mock (14)a 32.73 38.47
Flow cytometry analysis of HIV-1-infected PBMC by dual fluorescence
labeling with anti-CD4-FITC/anti-CD8-PE and anti-CD4-FITC/anti-CD3-
PE antibodies indicated that the CD4 receptor was initially downmodulated
following infection with HIV-1. CD4 downmodulation is represented by a
CD4 /CD3+ population that cannot be attributed to the CD4 /CD8+
population of cells. CD4 downmodulation was followed by CD4+
lymphocyte loss in PBMC infected with virus with an X4 phenotype
(LAI and MBC200) but not cells infected with virus with an R5 phenotype
(AD8, MBC676, and MBC925).
a Flow cytometry data of PBMC infected with LAI, AD8, and mock-
infected PBMC are shown in Fig. 2.
Fig. 3. The absence of the nef gene product does not exacerbate CD4+
lymphocyte loss in HIV-1-infected PBMC. PHA-PBMCs were mock-
infected or infected with MBCC18, MBCD36, NLAD, NLADDnef, NL4.3,
or NL4.3Dnef at an moi of 0.1. Virus replication was determined by cell-
free RT activity (a) and CD4+ lymphocyte loss was determined by flow
cytometry analysis of cells labeled with an anti-CD4-PE antibody (b). This
figure is representative of three infections using different PHA-PBMC
populations.
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cline in CD4+ lymphocytes observed in our acute model of
virus replication. Apoptosis was measured using TUNEL
(Fig. 5a) and results confirmed using propidium iodide
staining for cells in the hypodiploid fraction of the cell
cycle (Fig. 5b). Within 24 h of culture, both mock- and
virus-infected PBMCs underwent a modest increase in
apoptosis. This was most likely the result of the synchro-Table 2
Co-receptor usage by primary and reference HIV-1
Co-receptor usage
CD4 only CCR2b CCR3 CCR5 CCR8
NL4.3     
NLAD   + + + + + +
AD8   + + + + + +/
89.6  + + + + + + 
MBCD36  +/  + + + 
Co-receptor usage of HIV-1 was determined using Cf2-Luc cells as previously desc
et al., 2000) are derived from the Cf2th canine thymocyte cell line (Choe et al., 1
LTR. Cf2-Luc cells were transfected with a plasmid expressing CD4 only as a
alternative HIV-1 co-receptor and infected with equivalent amounts of each HIV-1
cultured for an additional 48 h. Cell lysates were prepared and assayed for lucifera
were scored as +++ (>50,000 luciferase activity units), ++ (between 30,000 and
activity units), +/ (between 5000 and 10,000 luciferase activity units), or  ( <
Isolate 89.6 has been included as an example of a dual tropic virus.nization process and culture conditions in vitro (McGahon
et al., 1995). Within 48 h, the level of apoptosis had
returned to preinfection levels indicating the transient
nature of this effect. Over the remaining period, there was
no significant increase in apoptosis in virus-infected cul-
tures relative to mock-infected cells. There was a small
decrease in the viability of cells, as determined by exclusion
of the vital dye trypan blue, in virus-infected cultures
relative to mock-infected cultures (Fig. 5c). However, thereCXCR4 CX3CR1 Gpr1 Gpr15 Strl33 Apj
+ + +     +
 +/  + + +
   + + +
+ ++  +/   +
+ ++     
ribed (Gorry et al., 2001, 2002a, 2002b). Cf2-Luc cells (Etemad-Moghadam
996), and stably express the luciferase gene under the control of the HIV-1
negative control, or co-transfected with plasmids expressing CD4 and an
virus. After overnight infection, the virus was removed and the cells were
se activity (Promega) according to the manufacturer’s protocol. Entry levels
50,000 luciferase activity units), + (between 10,000 and 30,000 luciferase
5000 luciferase activity units) as previously described (Gorry et al., 2001).
Fig. 4. Virus replication and CD4 antigen expression on HIV-1-infected PBMC. Cell-free RT activity (a and b) and CD4+ lymphocyte depletion (c and d) in
NL4.3, NLAD, AD8, or mock-infected mixed PHA-PBMC population infected with a moi of 0.0001 (a and c) or a synchronized preferred PHA-PBMC
population infected with a moi of 0.1 (b and d). The percentage of CD4+ lymphocytes was determined by flow cytometry analysis of cells labeled with an anti-
CD4-PE antibody. Results (a and c) are representative of infections using different mixed PHA-PBMC populations. Results (b and d) are representative of three
independent infections using the same donor cell population.
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infected with the R5 and X4 HIV-1 virus strains.
Apoptosis is detected in CD4+ X4 virus-infected cells after
the exponential phase of virus replication
Although apoptosis was not detected in whole PBMC
cultures infected with HIV-1, it has been reported to occur
in both HIV-1-infected and -uninfected CD4+ lymphocytes
as well as in uninfected CD8+ lymphocytes (Clerici et al.,
1996; Finkel et al., 1995; Gougeon et al., 1996; Herbein et
al., 1998a, 1998b; Meyaard et al., 1992; Muro-Cacho et
al., 1995). To investigate apoptosis in specific cell subsets,
we undertook dual fluorescence labeling with the TUNEL
assay and fluorescence labeled anti-CD4 or anti-p24 anti-
bodies. Labeling of cells for intracellular p24 expression
indicated that only a small percentage of the population
was infected. No more than 5% of NL4.3-infected PBMCs
were p24 positive, whereas as many as 7% of NLAD- and
13% of AD8-infected cells were p24-positive during the
exponential phase of virus replication. Dual labeling with
TUNEL did not identify a correlation between apoptosis
and antigen expression in infected cells or apoptosis in the
uninfected bystander population (Fig. 6).
Dual labeling for expression of CD4 and apoptosis
indicated that a similar percentage of CD4+ cells were
undergoing apoptosis in both HIV-1-infected and mock-
infected cell cultures (Figs. 6 and 7a). However, a signifi-
cant proportion of CD4+ lymphocytes was undergoing
apoptosis in NL4.3-infected cultures by 5 days postinfec-tion, at which time the majority of CD4+ lymphocyte loss
had occurred (Fig. 7b). It was unclear whether this increased
level of apoptosis reflected a constant level of apoptosis in a
declining cell population or an increasing level of apoptosis
that was associated with HIV-1-infection and masked by the
outgrowth of other cells, CD8+ lymphocytes in particular, in
the whole PBMC population (data not shown). To address
this question, we depleted the preferred PBMC population
of CD8+ lymphocytes and repeated this acute infection with
NL4.3 in either this depleted cell culture or parallel whole
PBMC population.
Apoptosis was assessed in parallel infections of whole
PBMC (Fig. 8a) and CD8-depleted cultures with NL4.3
(Fig. 8b) on days 2 and 6 postinfection at which time both
cultures contained similar levels of cell-free RT activity
(approximately 3000 cpm/Al; data not shown). Before virus
replication, 2 days postinfection, there was no significant
difference between the levels of apoptosis in uninfected or
NL4.3-infected whole PBMC or CD8-depleted cultures.
Whereas, on day 6, at the time of peak virus production,
there was an almost two-fold increase in the level of
apoptosis detected in CD8-depleted cells infected with
NL4.3 relative to mock-infected cells. This was in contrast
with parallel infections of whole PBMC population in which
there was no obvious difference between the levels of
apoptosis in NL4.3- and mock-infected cultures. Thus, the
increased levels of apoptosis detected in the analysis shown
in Fig. 7b are most likely to represent an increased level of
apoptosis associated with HIV-1 infection. Interestingly, in
these experiments, increased levels of apoptosis were
Fig. 5. Mechanisms of cell death in PBMC infected with HIV-1.
Synchronized preferred PHA-PBMCs were mock infected or infected with
NL4.3, NLAD, or AD8 at a moi of 0.1. Apoptosis was detected by
fluorescein-conjugated TUNEL (a) or the hypodiploid fraction following
propidium iodide staining for cell cycle analysis (b). Viable cells were
detected by exclusion of the viable dye trypan blue (c). Results are the
average of three independent infections of the same preferred PHA-PBMC
population used in Fig. 4. Fig. 4 is representative of the replication kinetics
and CD4+ lymphocyte loss observed in these infections. TUNEL and the
hypodiploid peak were assayed in duplicate for each infection. TUNEL
fluorescence was gated between 1% and 2% of mock-infected cells labeled
without enzyme. Propidium iodide-stained cells were gated to exclude
doublets and debris.
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shown). Thus supporting a role for bystander cell death late
in the infection period.Discussion
The variable replication of some HIV-1 isolates in
primary cells derived from different donors has been de-
scribed for both PBMC (Evans et al., 1987; Spira and Ho,
1995) and monocyte-derived macrophages (Cunningham et
al., 2000). This phenomenon was exploited in the present
study by selection of preferred PHA-PBMC populations,
which supported equivalent replication by virus with either
an R5 or X4 Env viral phenotypes. Replication was further
enhanced by the synchronization of the population, which
promoted an efficient single round of virus infection. We
used this system to show that the loss of CD4+ lymphocytes
from primary PBMC cultures is dependent on the viral
phenotype, in particular the gp120 region of HIV-1 Env,
and is not dependent on viral replication kinetics during
acute infection. Detailed kinetic studies indicated that apo-
ptosis was detected after the exponential phase of virus
replication in NL4-3 infected PBMC and after the majority
of cell loss had occurred. Thus, in this acute model of HIV-1
infection, apoptosis is not the primary mediator of CD4+ T-
lymphocyte loss.
The cytopathicity of the X4 virus NL4-3 in PBMC is
attenuated when the V3 region of Env is replaced with that
of an R5 virus (Penn et al., 1999). We further demonstrated
that the cytopathic profile of the chimeric virus NLAD was
identical to that of its host Env region AD8. Thus, establish-
ing that Env and in particular the gp120 region is the sole
mediator of cell loss observed in NL4.3-infected PBMC.
The method used to equalize X4 and R5 virus replication
kinetics enhanced the replication of the R5 virus phenotype.
Entry independent expression of an R5 Env has been shown
to effectively cause cytolysis in a membrane fusion-depen-
dent manner (LaBonte et al., 2000). Interestingly, cell fusion
was observed in AD8-infected cultures of synchronized
preferred PBMC (data not shown) and the level of CD4
expression in these cultures was somewhat decreased rela-
tive to a mixed PBMC population. Thus suggesting that the
R5-induced cytopathicity may have been enhanced under
the conditions used here. However, the R5 virus phenotype
was unable to attain the levels of cell loss detected in X4
virus-infected PBMC, thus supporting an intrinsic cytopa-
thicity associated with an X4 Env that is independent of
virus replication.
In this and a previous study, low levels of apoptosis were
detected in CD4+ lymphocytes of HIV-1-infected PBMC at
the peak of virus replication (Herbein et al., 1998a), but after
the majority of CD4+ lymphocyte loss has occurred (Fig.
8b). Thus, supporting the view that apoptosis occurs as a
consequence of CD4 + lymphocyte loss that is mediated by
a non-apoptotic mechanism. Apoptosis remains an impor-
tant mechanism of bystander cell loss in HIV-1 infection and
requires the presence of macrophages (Herbein et al., 1998a,
1998b). Despite the presence of macrophages in our primary
cell cultures, we did not consistently detect apoptosis in
bystander cells of the whole PBMC infections. However, in
Fig. 6. Apoptosis is not detected in the bystander cell population of HIV-1-infected PBMC during the acute phase of virus replication. Representative flow
cytometry analysis of NL4.3, NLAD, AD8, or mock-infected synchronized preferred PHA-PBMC. Dual fluorescence labeling for whole cell CD4 expression
(anti-CD4-PE) or viral antigen (anti-p24-PE) was performed in conjunction with fluorescein-conjugated TUNEL (TUNEL-FITC) to identify in which cell
population apoptosis was occurring. The phase of exponential virus replication and cell loss is shown (3 days postinfection).
Fig. 7. Apoptosis in NL4.3-infected PBMC is detected after CD4+
lymphocyte loss. Synchronized preferred PHA-PBMCs were infected with
NL4.3 (r), NLAD (j), or AD8 (H ) at a moi of 0.1 or mock-infected (o), and
dual fluorescence labeled for whole cell CD4 expression (anti-CD4-PE) and
fluorescein-conjugated TUNEL (TUNEL-FITC) to identify in which cell
population apoptosis was occurring. From flow cytometry analysis of the
percentage of apoptotic CD4+ (CD4+/TUNEL+) cells in the whole
population (a) and the proportion of CD4+ cells that undergo apoptosis
(TUNEL+) (b) was determined. Result shown is representative of three
independent infections of the same preferred PHA-PBMC population used
in Fig. 4. Fig. 4 is representative of the replication kinetics and CD4+
lymphocyte loss observed in these infections.
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the peak of virus replication when bystander cell death has
previously been detected.Fig. 8. Apoptosis is detected in NL4.3-infected CD8-depleted PBMC.
Apoptosis was detected by fluorescein-conjugated TUNEL assay of whole
(a) or CD8+-depleted (b) synchronized PHA-PBMC infected with NL4.3
(solid columns) at a moi of 0.1 or mock-infected (open columns). Example
shown is representative of three independent infections using two different
preferred PHA-PBMC populations; error bars represent the standard error
in duplicate samples assayed within the same infection.
V.A. Lawson et al. / Virology 327 (2004) 70–8278This study has implications in relation to the course of
disease in HIV-1 infection. The initial infection process in
vivo is almost exclusively by R5 viruses. Although we show
here that R5 viruses have lower cytopathicity for PBMC
than X4 viruses, it has been proposed that the high turnover
rate of memory T-cells that express CCR5 in vivo would
lead to high levels of R5 virus infection and cell death over
time (Davenport et al., 2002). This would eventually lead to
a decline in CD4+ T-lymphocyte numbers and the activation
of naive T-lymphocytes that are susceptible to infection with
more cytopathic X4 virus types. Infection and death of these
cells would then induce apoptosis as described here and in
bystander CD8+ T-lymphocytes (Herbein et al., 1998a;
Zaunders et al., 2003). However, the initial CD4+ lympho-
cyte loss is not mediated by apoptosis but most probably by
necrosis (Arnoult et al., 2003; Bolton et al., 2002; Borth-
wick et al., 1999; Kolesnitchenko et al., 1995, 1997;
LaBonte et al., 2000; Plymale et al., 1999). Certainly,
apoptosis may be occurring in infected cells, predominantly
in association with the X4 virus phenotype, but only
because of virus infection (Herbein et al., 1998b; Kreisberg
et al., 2001; Lenardo et al., 2002).
Our results indicate that the HIV-1 Nef protein is not
making a major contribution to cell death. The involvement
of HIV-1 Nef in controlling cell-mediated apoptosis remains
controversial (Greenway et al., 2002, 2003), but impor-
tantly, within the context of a viral infection, there is
potential interplay among all the HIV-1 proteins. Of partic-
ular note are Tat, Nef, and Vpr, all of which have been
identified as inducing or preventing apoptosis (Arnoult et
al., 2003; Greenway et al., 2002; Waldhuber et al., 2003).
Our results predict a temporal role for both apoptosis-
independent and -dependent HIV-1-mediated cell killing.
Early during the exponential phase of virus replication in
cells infected with an X4 virus, cell death occurs indepen-
dently of apoptosis. But at the peak of virus production,
further cell killing occurs via apoptotic mechanisms. This
two-phase cell killing has been observed in LAI-infected
Jurkat cells in which cell death is not attenuated by the
presence of Bcl-2 (an inhibitor of apoptosis) until the peak
of virus replication has been reached (Kolesnitchenko et al.,
1997). This may represent an early apoptosis-independent,
virus replication-dependent form of cell death followed by
replication-independent apoptosis, which is consistent with
the apoptosis observed in bystander cells of HIV-1-infected
individuals (Clerici et al., 1996; Finkel et al., 1995; Gou-
geon et al., 1996; Herbein et al., 1998b; Meyaard et al.,
1992; Muro-Cacho et al., 1995).Materials and methods
Preparation of primary cells
HIV-1-negative PBMCs were isolated by density gradi-
ent centrifugation over Ficoll hypaque according to themethod of Neate et al. (1987). Isolated cells were either
phytohemagglutinin activated for infection (PHA-PBMC) or
stored in liquid nitrogen for subsequent screening of their
ability to support the replication of X4 and R5 HIV-1
phenotypes.
Cells were PHA activated for 72 h in RPMI 1640
medium (ICN) supplemented with 10% (v/v) heat-inacti-
vated fetal calf serum (FCS; Gibco), penicillin (100 U/ml),
streptomycin (100 Ag/ml), L-glutamine (0.2 mM) (RF10),
and PHA (10 Ag/ml; Murex Biotech) before infection. These
PHA-PBMCs were then maintained in interleukin-2 (IL-2)
medium [RF10 containing IL-2 (10 U/ml; Boehringer Man-
nheim), polybrene (2 Ag/ml), and hydrocortisone (4 Ag/ml)]
at 1  106 cells/ml.
Preferred populations of PHA-PBMCs were selected for
their ability to support equivalent replication for both X4
and R5 viruses at a multiplicity of infection (moi) of 0.1–
10. These cells were synchronized by exposure to IL-2 (10
U/ml in IL-2 medium) for 6 h followed by incubation in
RF10 alone for 48 h to accumulate cells in G0/G1 phase of
the cell cycle as previously described (Stern and Smith,
1986). Synchronized PHA-PBMCs were then maintained in
IL-2 medium.
PHA-PBMCs were enriched for CD4+ lymphocytes by
depletion of CD8-expressing cells using M-450 CD8 Dyna-
beads according to the manufacturer’s instructions (Dynal).
After removal of CD8+ cells, the cell suspension was
pelleted and resuspended in IL-2 medium for infection.
Flow cytometric analysis indicated that after CD8 depletion,
more than 70% of the population was CD4+ and less than
10% of the population was CD8+ (data not shown).
Viral replication kinetics were determined in mixed
(two donor populations) PHA-PBMCs infected with an
equivalent moi from virus stocks. The mixed PHA-PBMC
population was incubated with virus stocks for 2 h at 37
jC, washed twice in PBS, and then resuspended in IL-2
medium at a concentration of 1  106/ml. Cell suspen-
sions (200 Al) were set up in duplicate wells of 96-well
plates. Cultures were half medium changed twice weekly
for 4 weeks and the supernatant stored at  20 jC to
determine cell-free reverse transcriptase (RT) activity. Cul-
tures were supplemented weekly with an equal number of
fresh donor PHA-PBMC.
Virus stocks
Infectious stocks of the molecular clones of LAI (Peden
et al., 1991), NL4-3 (Adachi et al., 1986), AD8 (Theodore et
al., 1996), and the chimeric clone NLAD (Freed et al.,
1994), and the nef-deleted clones NL4-3Dnef and NLAD
Dnef (Gibbs et al., 1994) were obtained from the Australian
National Centre in HIV Virology research (NCHVR) Re-
search Reagent program.
Australian HIV-1 isolates MBC200, MBC925, and
MBC676 were isolated from PBMC, CSF, and brain,
respectively, and were kindly provided by Ms. Sally Land
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(Cameron et al., 1996; Kiernan et al., 1990; Oelrichs et
al., 2000). Primary isolates MBCD36 (X4R5) and MBCC18
(R5) from the Sydney blood bank cohort (SBBC) (Deacon
et al., 1995) were both attenuated in nef/LTR (McPhee, D,
unpublished). Stocks were generated by a single passage in
a mixed PHA-PBMC population.
High titer stocks of virus from the HIV-1 molecular
clones NL4.3, NLAD, and AD8 were prepared from day
14 supernatants of infected PHA-PBMC. The supernatant
was clarified by low speed centrifugation at 146  g for 4
min and virus concentrated at 72000  g for 1 h. The
supernatant was discarded and the viral pellets were resus-
pended in IL-2 medium to one-tenth original volume. The
titer of virus obtained by this method was between 1  105
and 1  106 TCID50/ml.
Co-receptor usage
The co-receptor usage of each virus was determined
using Cf2-Luc cells as previously described (Gorry et al.,
2001, 2002a, 2002b). Cf2-Luc cells (Etemad-Moghadam et
al., 2000) are derived from the Cf2th canine thymocyte cell
line (Choe et al., 1996) and stably express the luciferase
gene under the control of the HIV-1 LTR. Cf2-Luc cells
were transfected with a plasmid expressing CD4 only as a
negative control or co-transfected with plasmids expressing
CD4 and an alternative HIV-1 co-receptor and infected with
equivalent amounts of each HIV-1 virus. After overnight
infection, the virus was removed and the cells were cultured
for an additional 48 h. Cell lysates were prepared and
assayed for luciferase activity (Promega) according to the
manufacturer’s protocol.
Virus replication
Cell-free HIV-1 RT activity was detected with a modified
micro-RT assay (Willey et al., 1988) using 33P instead of 32P
and read on a 1450 Microbeta Plus liquid scintillation
counter (Wallac). Infection supernatant was considered
positive if the RT activity was at least twice that of the
uninfected control supernatant.
Flow cytometric analysis
Samples were analyzed on a FACStar Plus flow cytom-
eter (Becton Dickinson) using an Innova laser (Coherent
Scientific) at the wavelength of 488 nm and output power of
200 mW. At least 10,000 events of interest were captured
per sample and the lymphocyte population was gated by
forward scatter (FSC) and side scatter (SSC) profiles. Data
were analyzed using the Winlist suite of programs (Verity
Software House, Version 2.0) on a PC platform.
Fluorescence-conjugated monoclonal antibodies (Becton
Dickinson) were used to detect the surface expression of
PBMC antigens (CD4, CD8, and CD3). Cells were washedwith 2.5% (v/v) FCS/0.1% (w/v) NaN3/PBS before the
addition of 10 Al of antibody and incubated on ice for
45–60 min. The cells were washed before being fixed in
1.0% (v/v) formaldehyde/PBS for analysis. Specific fluo-
rescence was gated relative to 5% of an isotype control
antibody.
To detect intracellular HIV-1 core antigen (p24), the cells
were washed and fixed on ice for 45 min in 4% (w/v)
paraformaldehyde (PFA; Merck)/PBS, pH 7.4. Free alde-
hydes were quenched with 0.1 M glycine/0.1% (w/v) NaN3/
PBS and permeabilized by treatment with 0.1% (v/v) Triton
X-100/PBS for 1 min. The fixed and permeabilized cells
were incubated on ice for 1 h with an anti-p24-specific
monoclonal antibody (2 Ag/ml; Olympus Corporation), 5%
(v/v) FCS/0.1% (w/v) NaN3/PBS followed by a secondary
fluorescein-conjugated anti-mouse antibody (Silenus). The
labeled cells were fixed in 1.0% (v/v) formaldehyde/PBS
and analyzed. Specific fluorescence was gated relative to
5% of mock-infected cells labeled with anti-p24 antibody.
Detection of apoptosis
Apoptotic cells have a reduced DNA content, which can
be detected as reduced fluorescence in flow cytometric
analysis of cell cycle using the dye propidium iodide.
Briefly, cells were washed once with PBS and fixed on
ice for 1 h in 1 ml 0.5% (v/v) formaldehyde/PBS. The cells
were washed in PBS, resuspended in 500 Al of propidium
iodide stain solution (3%(w/v) PEG, 50 Ag/ml propidium
iodide, 10 Ag/ml Dnase-free Rnase, 0.1% (v/v) TX-100 in 4
mM citric acid pH 7.8), and incubated for 20 min at 37 jC.
The cells were then left overnight at 4 jC after the addition
of 500 Al propidium iodide salt solution (3%(w/v) PEG, 50
Ag/ml propidium iodide, 0.1% (v/v) TX-100 in 0.4 mM
NaCl) and then analyzed. The apoptotic cell fraction was
gated below the G0/G1 peak of the cell cycle of the control
cell population with gating at channel 10 of the fluorescence
scale to eliminate debris.
Cleavage of nuclear DNA into oligonucleosome-sized
fragments was detected in individual cells using the fluo-
rescein-conjugated in situ cell death detection kit according
to the manufacturer’s instructions (Boehringer Mannheim).
This kit detects DNA cleavage by the TUNEL method,
which labels the blunt ends of double-stranded DNA breaks
with a fluorescein-labeled d-UTP using a terminal deoxy-
nucleotidyl transferase enzyme. Briefly, 0.2 or 1.0  106
cells were washed twice in 2–3 ml 1% (w/v) BSA/PBS. The
final pellet was resuspended in 1.0 ml freshly prepared 4%
(w/v) PFA/PBS, pH 7.4, and incubated at room temperature
for 30 min. Cells were washed once in 1% (w/v) BSA/PBS,
resuspended, and vortexed in 1.0 ml of 0.1% (v/v) TX-100/
PBS for 1 min. Thus permeabilized, the cells were imme-
diately washed twice in 1%(w/v) BSA/PBS and resus-
pended in 50 Al TUNEL reaction mixture and then
incubated for 1 h at 37 jC in a darkened, humidified
atmosphere. The cells were washed a final two times in
V.A. Lawson et al. / Virology 327 (2004) 70–82801%(w/v) BSA/PBS and resuspended in 1% (v/v) formalde-
hyde/PBS and stored at 4 jC until analyzed.
Apoptosis was detected in the CD4+ lymphocyte popu-
lation or HIV-1-infected cells by dual labeling for whole cell
CD4 or intracellular p24 antigen expression in conjunction
with TUNEL. Intracellular p24 antigen expression was
detected in fixed, permeabilized cells and labeled as de-
scribed above. Whole cell CD4 expression was detected by
preparing cells as described for intracellular p24 expression
and substituting the anti-CD4-PE-conjugated antibody for
the primary anti-p24 antibody, secondary labeling with the
fluorescein-conjugated antibody was omitted. Before final
fixation in 1% (v/v) formaldehyde/PBS, the anti-p24 or anti-
CD4 antibody labeled cells were washed once in 1% (w/v)
BSA/PBS and resuspended in 50 Al of TUNEL reaction
mixture and processed as described above for TUNEL
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